Severe 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) intoxication: Kinetics and trials to enhance elimination in two patients

Archives of Toxicology

Volumn 76, Issue 5-6, 2002, Pages 316-325

  Geusau, Alexandra ^a   Schmaldienst, Sabine ^a   Derfler, Kurt ^a   Päpke, Olaf ^b   Abraham, Klaus ^c  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b ERGO Forschungsgesellschaft mbH   (Germany)

^c HUMBOLDT UNIVERSITY   (Germany)

Author keywords

2,3,7,8 Tetrachlorodibenzo p dioxin; Dioxin; Kinetics; Lipid apheresis; Olestra; TCDD

Indexed keywords

2,3,7,8 TETRACHLORODIBENZO PARA DIOXIN; LOW DENSITY LIPOPROTEIN; SUCROSE POLYESTER; ANTIDOTE; DRUG DERIVATIVE; FATTY ACID; SUCROSE;

ADULT; APHERESIS; ARTICLE; BLOOD LEVEL; CALCULATION; CASE REPORT; CONTROLLED STUDY; DISEASE SEVERITY; DRUG EFFECT; DRUG INTOXICATION; FAT INTAKE; FEMALE; HUMAN; LIPID BLOOD LEVEL; LIVER METABOLISM; PRIORITY JOURNAL; TREATMENT OUTCOME; BLOOD; CLINICAL TRIAL; DRUG DETOXIFICATION; FOLLOW UP; HALF LIFE TIME; INTOXICATION; METABOLISM; POLLUTANT; TISSUE DISTRIBUTION; URINE;

ADULT; ANTIDOTES; BLOOD COMPONENT REMOVAL; DIETARY FATS; ENVIRONMENTAL POLLUTANTS; FATTY ACIDS; FEMALE; FOLLOW-UP STUDIES; HALF-LIFE; HUMAN; LIPOPROTEINS, LDL; METABOLIC DETOXICATION, DRUG; POISONING; SUCROSE; SUPPORT, NON-U.S. GOV'T; TETRACHLORODIBENZODIOXIN; TISSUE DISTRIBUTION; HUMANS;

SOLANUM TUBEROSUM;

EID: 0036016869     PISSN: 03405761     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00204-002-0345-7     Document Type: Article

References (44)

1. Pharmacokinetics and biological activity of 2,3,7,8-tetrachlorodibenzo-p-dioxin: 1. Dose-dependent tissue distribution and induction of hepatic ethoxyresorufin O-deethylase in rats following a single injection
2. Intake, fecal excretion, and body burden of polychlorinated dibenzo-p-dioxins and dibenzofurans in breast-fed and formula-fed infants
3. Time course of PCDD/PCDF/PCB concentrations in breast-feeding mothers and their infants
4. Severe 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) intoxication: Insights into the measurement of hepatic CYP1A2 induction
5. Therapeutic efficiency of lipoprotein(a) reduction by low-density lipoprotein immunoapheresis
6. The Seveso studies on early and long-term effects of dioxin exposure: A review
7. Modeling of the toxicokinetics of polychlorinated dibenzo-p-dioxins and dibenzofurans in mammalians, including humans. I. Nonlinear distribution of PCDD/PCDF body burden between liver and adipose tissue
8. Modeling of the toxicokinetics of polychlorinated dibenzo-p-dioxins and dibenzofurans in mammalians, including humans. II. Kinetics of absorption and distribution of PCDDs/PCDFs
9. TCDD kinetics in Seveso patients
10. Blood lipid concentration of dioxins and dibenzofurans causing chloracne
11. Chloracne and its potential clinical implications
12. Role of CYP1A2 in hepatic sequestration of dioxin: Studies using CYP1A2 knockout mice
13. Food additives permitted for direct addition to food for human consumption; olestra
14. Elimination of polychlorinated dibenzo-p-dioxins and dibenzofurans in occupationally exposed persons
15. Review and analysis of the effects of olestra, a dietary fat substitute, on gastrointestinal function and symptoms
16. Olestra increases faecal excretion of 2,3,7,8-tetrachlorodibenzo-p-dioxin
17. Punctate keratoderma-like lesions on the palms and soles in a patient with chloracne: A new clinical manifestation of dioxin intoxication?
18. Severe 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) intoxication: Clinical and laboratory effects
19. Cutaneous elimination of 2,3,7,8-tetrachlorodibenzo-p-dioxin
20. Olestra: Assessing its potential to interact with drugs in the gastrointestinal tract
21. Pharmocokinetics in veterans of operation Ranch Hand: 10-year follow-up
22. Pharmacokinetics of 2,3,7,8-tetrachlorodibenzo-p-dioxin in Seveso adults and veterans of operation Ranch Hand
23. Dioxin health effects on humans twenty years after Seveso: A summary
24. A non-absorbable dietary fat substitute enhances elimination of persistent lipophilic contaminants in humans
25. Half-life of 2,3,7,8-tetrachlorodibenzo-p-dioxin in serum of Seveso adults: Interim report
26. Serum levels in Seveso, Italy, population in 1976
27. Induced lactation: A study of 37 non-puerperal mothers
28. Assessment of past exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin using blood lipid analyses
29. PCDD/PCDFs in whole blood samples of unexposed persons
30. Determination of PCDD/Fs in human blood, a fast and sensitive method
31. PCDD/PCDF: Human background data for Germany, a 10-year experience
32. Partitioning of in vivo bound PCDDs/PCDFs among various compartments in whole blood
33. Pharmacokinetics of 2,3,7,8-TCDD in man
34. Three-year treatment of familial heterozygous hypercholesterolemia by extracorporeal low-density lipoprotein immunoadsorption with polyclonal apolipoprotein B antibodies
35. Clearance of PCDD/Fs via the gastrointestinal tract in occupationally exposed persons
36. Intestinal excretion of toxic substances
37. Elimination of polychlorinated dibenzofurans (PCDFs) and polychlorinated biphenyls (PCBs) from human blood in the Yusho and Yu-Cheng rice oil poisonings
38. Comparison of dioxin and dibenzofuran levels on whole blood plasma and adipose tissue on a lipid basis
39. Prospective randomised cross-over comparison of three LDL-apheresis systems in statin pretreated patients with familial hyercholesterolemia
40. Determination of part-per-trillion levels of polychlorinated dibenzofurans and dioxins in environmental samples
41. World Health Organisation international intercalibration study on dioxins and furans in human milk and blood
42. The toxicokinetics and metabolism of polychlorinated dibenzo-p-dioxins (PCDDs) and dibenzofurans (PCDFs) and their relevance for toxicity
43. A new TOBEC instrument and procedure for the assessment of body composition: Use of Fourier coefficients to predict lean body mass and total body water
44. Morbidity follow up study of BASF employees exposed to 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) after a 1953 chemical reactor incident